Patents by Inventor Aalt Bast

Aalt Bast has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150104868
    Abstract: The present invention relates to methods of using meso-1,2,3,4-tetrahydroxybutane for the maintenance and/or improvement of biological cell function and activity, and for the prevention of improper cell functioning or cell death, in vitro, ex vivo, and in vivo over time and/or during exposure to stress. Meso-1,2,3,4-tetrahydroxybutane can be used to promote cell survival and as a cell protection agent, to increase cell viability, and to improve conversion of progenitor or stem cells to mature cells, whether in vitro, in vivo, ex-vivo, or transplanted.
    Type: Application
    Filed: April 19, 2013
    Publication date: April 16, 2015
    Applicant: CARGILL, INC.
    Inventors: Alvin Berger, Aalt Bast, Petrus Wilhelmus Hubertus De Cock, Gerardus Johannes Martinus Den Hartog, Jean-Claude Marie-Pierre Ghislain De Troostembergh
  • Publication number: 20130330431
    Abstract: Olive extracts comprising hydroxytyrosol are effective in promoting muscle health in both animals and humans which are subject to muscle damage, muscle pain and muscle soreness due to exercise. The olive extracts can decrease the accumulation of lactic acid present post-exercise, and can also work by maintaining glutathione levels.
    Type: Application
    Filed: June 3, 2013
    Publication date: December 12, 2013
    Applicant: DSM IP ASSETS B.V.
    Inventors: Saskia Johannes RIETJENS, Aalt BAST, Guido Rembertus Michiel Marie HAENEN, Lucas Cyril Gerard VAN DER HEYDEN
  • Publication number: 20120165576
    Abstract: The present invention relates to the use of erythritol for the up regulation of the SOD2 enzyme in mammals and prevention or treatment of hypertension. More specifically, erythritol protects against the development of endothelial dysfunction and related reduction of vasodilatation and erythritol protects against hemolysis-induced vasoconstriction.
    Type: Application
    Filed: July 26, 2010
    Publication date: June 28, 2012
    Applicant: CARGILL, INCORPORATED
    Inventors: Aalt Bast, Alvin Berger, Petrus Wilhelmus Hubertus Antonius De Cock, Gerardus Johannes Martinus Den Hartog
  • Publication number: 20110172301
    Abstract: The present invention describes the use of a composition comprising a compound according to formula (1) to retain or restore muscle health: formula (1) wherein: R can be H, OH or CH3O; R1 can be H, (CH2)nOR2 wherein: n is 1, 2 or 3 R2 is H, COCH3 or formula (2) wherein m is 1, 2 or 3 with the proviso that R and R1 are not H at the same time. The invention furthermore relates to the use of a compound according to formula (1) in the manufacture for a composition to retain or restore muscle health, thereby for example preventing and/or treating muscle damage due to exercise. More specifically, such composition includes food, beverages, supplements and feed.
    Type: Application
    Filed: March 25, 2011
    Publication date: July 14, 2011
    Applicant: DSM IP ASSETS B.V.
    Inventors: Arie Karst Kies, Saskia Johannes Rietjens, Guido Rembertus Michiel Marie Haenen, Aalt Bast
  • Publication number: 20110052750
    Abstract: Olive extracts comprising hydroxytyrosol are effective in promoting muscle health in both animals and humans which are subject to muscle damage, muscle pain and muscle soreness due to exercise. The olive extracts can decrease the accumulation of lactic acid present post-exercise, and can also work by maintaining glutathione levels.
    Type: Application
    Filed: October 5, 2007
    Publication date: March 3, 2011
    Inventors: Johannes S. Rietjens, Aalt Bast, Guido R.M.M. Haenen, Lucas C.G. Heyden Van Der
  • Publication number: 20090215713
    Abstract: The present invention provides the use of ATP for the manufacture of a medicine comprising ATP as an active ingredient for exerting a preventive or therapeutic pharmacological effect when administered to a mammal, preferably a human, selected from the group consisting of: a. modulating oxidative stress and the effects thereof by favourably affecting the formation or scavenging of aggressive hydroxyl radicals; b. modulating the inflammatory response to a strong external insult such as endotoxin (LPS) and/or phytohaemagglutinin, even under conditions of severe oxidative stress; c. inhibiting the inflammatory response to a strong external insult such as endotoxin (LPS) and/or phytohaemagglutinin under conditions of severe oxidative stress; d. exerting a local protective effect against oxidative stress in the intestine, thus preventing intestinal damage induced by several types of medication such as non steroid anti-inflammatory drugs (NSAIDs); e.
    Type: Application
    Filed: May 23, 2005
    Publication date: August 27, 2009
    Applicant: UNIVERSITEIT VAN MAASTRICHT
    Inventors: Pieter C. Dagnelie, Els L.R. Swennen, Aalt Bast, Arno T.P. Skrabanja, Sandra Beijer, Martijin J.I. Bours
  • Publication number: 20070287746
    Abstract: The present invention describes the use of a composition comprising a compound according to formula (1) to retain or restore muscle health: formula (1) wherein: R can be H, OH or CH3O; R1 can be H, (CH2)nOR2 wherein: n is 1, 2 or 3 R2 is H, COCH3 or formula (2) wherein m is 1, 2 or 3 with the proviso that R and R1 are not H at the same time. The invention furthermore relates to the use of a compound according to formula (1) in the manufacture for a composition to retain or restore muscle health, thereby for example preventing and/or treating muscle damage due to exercise. More specifically, such composition includes food, beverages, supplements and feed.
    Type: Application
    Filed: November 15, 2005
    Publication date: December 13, 2007
    Inventors: Arie Kies, Saskia Rietjens, Guido Rembertus Haenen, Aalt Bast
  • Patent number: 5925668
    Abstract: The present invention provides compounds with antioxidant activity effective in treating free radical mediated diseases.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: July 20, 1999
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Gerreke Biewenga, Guido R. M. M. Haenen, Aalt Bast